{"document": {"publication": "Tag My News", "full_text": "germany's healthcare cost-effectiveness watchdog iqwig said alzheimer's disease drug memantine provides a benefit, one and a half years after its initial rejection.", "title": "german cost agency changes tack on alzheimer's drug", "line_count": 1, "filename": "21372", "publication_date": "26-04-2011 20:50:35", "lines_and_colors": [["germany's healthcare cost-effectiveness watchdog iqwig said alzheimer's disease drug memantine provides a benefit, one and a half years after its initial rejection.", {}]]}}